Capstan Medical
Capstan Medical Raises $110M Series C | Cardiac Surgical Robotics
Capstan Medical Closes $110M for Surgical Robotics
Capstan Medical, a company creating minimally invasive technologies to treat heart valve disorders, has raised $110 million in Series C funding.
The round was led by Eclipse Ventures with participation from Intuitive Ventures, Meritech Capital, and Gideon Strategic Partners.
Key Highlights
- Total funding to date: $141.4 million
- Advanced surgical robotics for cardiac procedures
- Backed by Intuitive Surgical venture arm
Company Overview
Capstan Medical is developing advanced surgical robotics and instrumentation for minimally invasive cardiac procedures, focusing on heart valve repair and replacement.
Company Info
Investors (3)
Share
Related Reports
Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform
Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.
Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation
French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free